A critical discovery in cancer study is emerging with the use of nanobodies to reactivate damaged p53. This essential malignant inhibitor protein is frequently disabled in many forms of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research